Name | Number of supported studies | Average coverage | |
---|---|---|---|
hepatocyte | 3 studies | 54% ± 16% |
Insufficient scRNA-seq data for expression of F11 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 5895.07 | 226 / 226 | 96% | 35.44 | 391 / 406 |
pancreas | 100% | 1279.06 | 328 / 328 | 58% | 3.18 | 104 / 178 |
kidney | 100% | 408.10 | 89 / 89 | 20% | 0.95 | 181 / 901 |
lung | 85% | 140.83 | 489 / 578 | 15% | 0.51 | 170 / 1155 |
stomach | 71% | 10.48 | 255 / 359 | 4% | 0.11 | 12 / 286 |
intestine | 69% | 16.24 | 663 / 966 | 6% | 0.22 | 32 / 527 |
brain | 63% | 6.38 | 1677 / 2642 | 1% | 0.01 | 5 / 705 |
ovary | 64% | 6.14 | 115 / 180 | 0% | 0.01 | 1 / 430 |
blood vessel | 63% | 6.48 | 846 / 1335 | 0% | 0 | 0 / 0 |
spleen | 48% | 9.44 | 115 / 241 | 0% | 0 | 0 / 0 |
muscle | 44% | 4.35 | 351 / 803 | 0% | 0 | 0 / 0 |
adrenal gland | 41% | 2.88 | 105 / 258 | 2% | 0.30 | 4 / 230 |
prostate | 42% | 4.09 | 102 / 245 | 0% | 0 | 0 / 502 |
bladder | 38% | 2.86 | 8 / 21 | 2% | 0.07 | 9 / 504 |
uterus | 38% | 4.00 | 65 / 170 | 0% | 0.03 | 2 / 459 |
esophagus | 32% | 2.73 | 459 / 1445 | 5% | 0.15 | 10 / 183 |
thymus | 32% | 2.32 | 212 / 653 | 0% | 0.00 | 1 / 605 |
heart | 23% | 1.60 | 198 / 861 | 0% | 0 | 0 / 0 |
adipose | 23% | 2.49 | 273 / 1204 | 0% | 0 | 0 / 0 |
breast | 16% | 1.41 | 72 / 459 | 0% | 0.00 | 2 / 1118 |
peripheral blood | 15% | 3.01 | 135 / 929 | 0% | 0 | 0 / 0 |
skin | 6% | 0.54 | 116 / 1809 | 0% | 0 | 0 / 472 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0031639 | Biological process | plasminogen activation |
GO_0007596 | Biological process | blood coagulation |
GO_0051919 | Biological process | positive regulation of fibrinolysis |
GO_0005615 | Cellular component | extracellular space |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0008201 | Molecular function | heparin binding |
GO_0070009 | Molecular function | serine-type aminopeptidase activity |
GO_0005515 | Molecular function | protein binding |
GO_0004252 | Molecular function | serine-type endopeptidase activity |
Gene name | F11 |
Protein name | Coagualtion factor XI Coagulation factor XI (FXI) (EC 3.4.21.27) (Plasma thromboplastin antecedent) (PTA) [Cleaved into: Coagulation factor XIa heavy chain; Coagulation factor XIa light chain] Coagulation factor XI |
Synonyms | |
Description | FUNCTION: Factor XI triggers the middle phase of the intrinsic pathway of blood coagulation by activating factor IX. |
Accessions | ENST00000264691.4 A0A411HAZ9 ENST00000452239.1 ENST00000492972.6 Q9UEG0 P03951 ENST00000403665.7 [P03951-1] D6RB32 X6R3B1 H0Y596 |